Parkinson's medication shows promise in treating treatment-resistant depression
Reported byMedicalXpress ↗·Sourced by Goodlede
A peer-reviewed study published in Nature Medicine found that a Parkinson's disease medication can be used as an add-on therapy to alleviate symptoms of treatment-resistant depression, particularly addressing motivation loss and anhedonia in patients who haven't responded to standard treatments.
This is a single study; the medication has not yet been approved for depression treatment, and effectiveness may vary among patients. Long-term safety and efficacy data in depression populations are not yet established.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at MedicalXpress
Read original story ↗↻ Refreshed daily
More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Science
'Janus-faced' nanomaterials pave the way for selectively capturing radioactive pollutants
Phys.org Science · Caution
Science
The missing notebooks that solved a 55-million-year-old fossil mystery
ScienceDaily Top Science · Verified
Science
Giant underground neutrino detector brings scientists closer to cracking the neutrino puzzle
ScienceDaily Top Science · Caution